Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Kantarjian H, Thomas D, O'Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ.
Cancer. 2004 Dec 15;101(12):2788-801. doi: 10.1002/cncr.20668.
PMID:15481055
Blinatumomab, a Bispecific T-cell Engager (BiTE()) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications.
Zhu M, Wu B, Brandl C, Johnson J, Wolf A, Chow A, Doshi S.
Recognition of acute lymphoblastic leukemia and lymphocytes cell subtypes in microscopic images using random forest classifier.
Mirmohammadi P, Ameri M, Shalbaf A.
Phys Eng Sci Med. 2021 Jun;44(2):433-441. doi: 10.1007/s13246-021-00993-5. Epub 2021 Mar 22.
PMID:33751420
PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity.
Koller P, Baran N, Harutyunyan K, Cavazos A, Mallampati S, Chin RL, Jiang Z, Sun X, Lee HH, Hsu JL, Williams P, Huang X, Curran MA, Hung MC, Konopleva M.
Acute Lymphoblastic Leukemia Detection and Classification of Its Subtypes Using Pretrained Deep Convolutional Neural Networks.
Shafique S, Tehsin S.
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818802789. doi: 10.1177/1533033818802789.
PMID:30261827
Acute Lymphoblastic Leukemia in Combined Methylmalonic Acidemia and Homocysteinemia (cblC Type): A Case Report and Literature Review.
Zhu J, Wan S, Zhao X, Zhu B, Lv Y, Jiang H.
Front Genet. 2022 Apr 14;13:856552. doi: 10.3389/fgene.2022.856552. eCollection 2022.
PMID:35495149
Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
Ahmed IO, Ochogwu LO, Owojuyigbe TO, Akinola NO, Durosinmi MA.
J Med Case Rep. 2021 Oct 8;15(1):504. doi: 10.1186/s13256-021-03060-5.
PMID:34625105
Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).
Hardianti MS, Tatsumi E, Syampurnawati M, Furuta K, Suzuki A, Saigo K, Kawano S, Takenokuchi M, Kumagai S, Matsuo Y, Koizumi T, Takeuchi M.